Emily Pimblett - ELYM Old Principal Officer
Executive
Emily Pimblett is Principal Officer of ELYM Old
| Age | 40 |
| Phone | 877 354 3689 |
| Web | https://eliemtx.com |
Emily Pimblett Latest Insider Activity
Tracking and analyzing the buying and selling activities of Emily Pimblett against ELYM Old stock is an integral part of due diligence when investing in ELYM Old. Emily Pimblett insider activity provides valuable insight into whether ELYM Old is net buyers or sellers over its current business cycle. Note, ELYM Old insiders must abide by specific rules, including filing SEC forms every time they buy or sell ELYM Old'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Emily Pimblett few days ago Acquisition by Emily Pimblett of 5000 shares of Climb Bio subject to Rule 16b-3 | ||
Emily Pimblett over a month ago Acquisition by Emily Pimblett of 5000 shares of Climb Bio subject to Rule 16b-3 | ||
Emily Pimblett over three months ago Acquisition by Emily Pimblett of 5000 shares of Climb Bio subject to Rule 16b-3 | ||
Emily Pimblett over six months ago Disposition of tradable shares by Emily Pimblett of Eliem Therapeutics at 8.06 subject to Rule 16b-3 |
ELYM Old Management Efficiency
The company has return on total asset (ROA) of (0.2454) % which means that it has lost $0.2454 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.3835) %, meaning that it created substantial loss on money invested by shareholders. ELYM Old's management efficiency ratios could be used to measure how well ELYM Old manages its routine affairs as well as how well it operates its assets and liabilities.ELYM Old currently holds 349 K in liabilities with Debt to Equity (D/E) ratio of 0.0, which may suggest the company is not taking enough advantage from borrowing. ELYM Old has a current ratio of 17.13, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about ELYM Old's use of debt, we should always consider it together with its cash and equity.
Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Karin Heidemann | Champions Oncology | N/A | |
| Robert JD | Pmv Pharmaceuticals | 63 | |
| Jaya Goyal | PepGen | 56 | |
| Stephen JD | Shattuck Labs | 50 | |
| MBA CFA | PepGen | N/A | |
| Morgan Conn | Century Therapeutics | 56 | |
| Daniel George | Anebulo Pharmaceuticals | 55 | |
| Bruce Close | Acrivon Therapeutics, Common | N/A | |
| Michael Carulli | Pmv Pharmaceuticals | 51 | |
| Emiko Bryant | PepGen | N/A | |
| Joshua JD | AN2 Therapeutics | 47 | |
| Thomas PharmD | Shattuck Labs | N/A | |
| Stephen Yu | Aerovate Therapeutics | N/A | |
| Michael Naso | Century Therapeutics | N/A | |
| Michael Covarrubias | Rezolute | N/A | |
| Binh Vu | Pmv Pharmaceuticals | N/A | |
| MaryAlice JD | Acrivon Therapeutics, Common | 51 | |
| Daniel Steiner | Molecular Partners AG | N/A | |
| Ling Zhou | Adagene | N/A | |
| Hayley Parker | PepGen | N/A | |
| Stefan Abele | Pharvaris BV | 55 | |
Management Performance
| Return On Equity | -0.38 | |||
| Return On Asset | -0.25 |
ELYM Old Leadership Team
Elected by the shareholders, the ELYM Old's board of directors comprises two types of representatives: ELYM Old inside directors who are chosen from within the company, and outside directors, selected externally and held independent of ELYM. The board's role is to monitor ELYM Old's management team and ensure that shareholders' interests are well served. ELYM Old's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, ELYM Old's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Erin Lavelle, COO VP | ||
| MD MBA, Chief Officer | ||
| James JD, Gen VP | ||
| Jo PalmerPhillips, Chief Officer | ||
| Andrew MD, Principal Chairman | ||
| Valerie Morisset, Chief Development | ||
| Emily Pimblett, Principal Officer | ||
| BAO BCh, President CEO | ||
| Susan MS, VP Affairs | ||
| Robert MBA, CEO Pres | ||
| MBA MD, Interim Officer | ||
| Nishi MD, Senior Development |
ELYM Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is ELYM Old a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.38 | |||
| Return On Asset | -0.25 | |||
| Current Valuation | 23.84 M | |||
| Shares Outstanding | 67.06 M | |||
| Shares Owned By Insiders | 10.38 % | |||
| Shares Owned By Institutions | 77.67 % | |||
| Number Of Shares Shorted | 1.15 M | |||
| Price To Book | 0.99 X | |||
| EBITDA | (13.65 M) | |||
| Net Income | (35.12 M) |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Other Consideration for investing in ELYM Stock
If you are still planning to invest in ELYM Old check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the ELYM Old's history and understand the potential risks before investing.
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |